Aspect Biosystems
Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
Domain
aspectbiosystems.com
Country
CanadaIndustry
Artificial Intelligence (AI)Employees
101-250
Last Funding
$115.0M
Founded
2013
Tech Stack (22 technologies)
Frequently Asked Questions
What technologies does Aspect Biosystems use?+
Aspect Biosystems uses 22 technologies including cdnjs, Google Analytics, Google Font API.
What industry is Aspect Biosystems in?+
Aspect Biosystems operates in the Artificial Intelligence (AI) industry.
Where is Aspect Biosystems based?+
Aspect Biosystems is headquartered in Canada.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026